During the Track Record Period, Beijing Shengji Power Technology Co., Ltd. (北京生機動力科技有限公司) (“Shengji Power”) was our Joint Venture, and we also appointed a Director to Shengji Power.
Business · p. 185
Pinggao Xinsong was also our channel partner.
Business · p. 185
Our Directors believe that these transactions were conducted on normal commercial terms and on an arm’s length basis in the ordinary and usual course of business, and did not distort our results of operations or make our historical results not reflective of our future performance.
(i) amounts due from related parties of RMB16.7 million; (ii) receivables of reimbursable R&D expense of RMB12.5 million and (iii) deferred [REDACTED] of RMB7.5 million.
Financial Information · p. 231
Our Directors are of the view that each of the related party transactions was conducted in the ordinary course of business on an arm's-length basis and with normal commercial terms between the relevant parties.
As of December 31, 2025, we had outstanding balances with related parties of RMB220.2 million that are included in trade and other receivables, RMB0.2 million that are included in trade and other payables and RMB12.8 million that are included in lease liabilities.
Financial Information · p. 257
As of December 31, 2025, we had a current loan from the entity under common control of the Controlling Shareholders with a principal amount of RMB310 million, which is maturing at the end of 2026.
Financial Information · p. 252
Our Directors believe that our transactions with the related parties during the Track Record were conducted in the normal course of business and on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Our Directors confirm that these transactions were conducted in the ordinary course of our business, on an arm’s length basis and with normal commercial terms between the relevant parties.
Our Directors believe that our transactions with related parties during the Track Record Period were conducted on an arm's length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
As our business scale expanded, we acquired the trademarks of DAHON from DNA at a consideration of USD2.2 million determined with reference to the appraise value of the trademarks to facilitate our brand building.
Financial Information · p. 271
As of December 31, 2022, 2023 and 2024 and April 30, 2025, amounts due from DNA recognized as either amounts due from related parties or trade receivables were RMB19.2 million, RMB7.2 million, RMB4.6 million and RMB4.6 million, respectively.
Financial Information · p. 271
Our Directors believe that our transactions with related parties during the Track Record Period, which were trade in nature, were conducted on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
During the Track Record Period, we had entered into certain related party transactions, details of which are set out in Note 34 to the Accountants' Report in Appendix I to this prospectus.
Financial Information · p. 389
All of our related party balances as of December 31, 2022, 2023 and 2024 were trade in nature.
Financial Information · p. 390
Our Directors confirm that all of our related party transactions during the Track Record Period set out in Note 34 to the Accountants' Report in Appendix I to this prospectus were conducted on an arm's length basis and would not distort our results of operations or make our historical results not reflective of our future performance.
Historically, we operated certain restaurants owned by our connected persons pursuant to our cooperation agreements with such parties.
Business · p. 166
Our amounts due from related parties decreased to nil as of December 31, 2024 due to the termination of cooperation agreements with our connected persons following the acquisition of Hangzhou Greentea and its subsidiary on December 25, 2024.
Financial Information · p. 298
Our Directors believe that the related party transactions were carried out on an arm's length basis and will not distort our results during the Track Record Period or make such results not reflective of our future performance.
Our average turnover days of trade receivables attributable to related parties further increased to 106.7 days for 6M2024, mainly due to the increase in past due trade receivables of Related Party A.
Financial Information · p. 451
Other receivables from related parties included temporary payment on behalf of related party which was incurred before our acquisition of Anhui Haicui and was subsequently settled as at the Latest Practicable Date.
Financial Information · p. 452
With respect to the related party transactions set out in the Accountants’ Report in Appendix I to this prospectus, our Directors confirm that all related party transactions during the Track Record Period were conducted on normal commercial terms that are reasonable and in the interest of our Group as a whole.
Our amounts due from related parties increased by 48.5% from RMB16.7 million as of December 31, 2021 to RMB24.7 million as of December 31, 2022, decreased to RMB22.6 million as of December 31, 2023, and then increased to RMB72.2 million as of June 30, 2024.
Financial Information · p. 538
During the Track Record Period, the related parties purchase drug and medical device products from us, and the credit terms we have granted are in line with our common practice.
Financial Information · p. 538
Our Group has entered into and will continue to engage in certain transactions with Huadong Medicine and Zhongmei Huadong, which will constitute continuing connected transactions upon the Listing.
Our Directors are of the view that each of the related party transactions set out in Note 34 the Accountant’s Report in Appendix I was conducted in the ordinary course of business and with normal commercial terms between the relevant parties.
Financial Information · p. 400
Our Directors are also of the view that our related party transactions during the Track Record Period would not distort our track record results or cause our historical results to become non-reflective of our future performance.
During the Track Record Period, we had entered into a number of related party transactions, see note 36 to the Accountants’ Report in Appendix I to this prospectus.
Financial Information · p. 480
Our work in progress as of December 31, 2021 and 2022 entirely represented the accumulated costs incurred in connection with a NRE project related to SDS with Mobvoi JV.
Financial Information · p. 462
Our Directors believe that our transactions with related parties during the Track Record Period had been conducted on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
We recorded amounts due from related parties of RMB149.5 million, RMB91.6 million and RMB0.6 million as of December 31, 2021, 2022 and 2023, respectively.
Financial Information · p. 322
Our amounts due from related parties comprise (i) the trade in nature portion, representing receivables from franchised ChaPanda stores owned and operated by certain management or executive Directors who were key management personnel of our operating entities or subsidiaries, and (ii) the non-trade in nature portion, representing the rental deposits for our office spaces leased from related parties and advances to our related parties, which were unsecured, interest-free and repayable on demand.
Financial Information · p. 322
Our Directors have represented that the amounts due from related parties have been fully settled as of December 31, 2023, save for the above-mentioned rental deposits in the non-trade in nature portion.